Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,177,791 papers from all fields of science
Search
Sign In
Create Free Account
triheptanoin
Known as:
glyceroltriheptanoate
, glyceryl triheptanoate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Triglycerides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
T. Tefera
,
K. Borges
Frontiers in Neuroscience
2017
Corpus ID: 13347741
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease primarily characterized by loss of motor neurons in…
Expand
Review
2016
Review
2016
Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
E. Coppen
,
R. Roos
Drugs
2016
Corpus ID: 16192955
There are currently no effective pharmacological agents available to stop or prevent the progression of Huntington’s disease (HD…
Expand
Highly Cited
2015
Highly Cited
2015
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
F. Mochel
,
Elodie Hainque
,
+13 authors
E. Roze
Journal of Neurology Neurosurgery & Psychiatry
2015
Corpus ID: 2728062
Objective On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we…
Expand
Highly Cited
2014
Highly Cited
2014
Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
J. Pascual
,
Peiying Liu
,
+12 authors
Hanzhang Lu
JAMA Neurology
2014
Corpus ID: 38884379
IMPORTANCE Disorders of brain metabolism are multiform in their mechanisms and manifestations, many of which remain…
Expand
2014
2014
Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice
Min Jung Park
,
S. Aja
,
+5 authors
G. Ronnett
PLoS ONE
2014
Corpus ID: 14937173
Rett syndrome (RTT) is an autism spectrum disorder (ASD) caused by mutations in the X-linked MECP2 gene that encodes methyl-CpG…
Expand
Review
2012
Review
2012
GLUT1 deficiency syndrome in clinical practice
J. Klepper
Epilepsy Research
2012
Corpus ID: 43104780
Review
2010
Review
2010
Disorders of muscle lipid metabolism: Diagnostic and therapeutic challenges
P. Laforêt
,
C. Vianey-Saban
Neuromuscular Disorders
2010
Corpus ID: 30613830
Highly Cited
2005
Highly Cited
2005
Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin.
Y. Nishi
,
Hiroshi Hiejima
,
+7 authors
M. Kojima
Endocrinology
2005
Corpus ID: 32910715
Ghrelin, an acylated brain and gut peptide, is primarily produced by endocrine cells of the gastric mucosa for secretion into the…
Expand
Highly Cited
2005
Highly Cited
2005
Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy.
F. Mochel
,
P. Delonlay
,
+5 authors
J. Saudubray
Molecular Genetics and Metabolism
2005
Corpus ID: 12453991
Highly Cited
2002
Highly Cited
2002
Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.
C. Roe
,
L. Sweetman
,
D. Roe
,
F. David
,
H. Brunengraber
Journal of Clinical Investigation
2002
Corpus ID: 4718403
The current dietary treatment of long-chain fatty acid oxidation defects (high carbohydrate with medium-even-chain triglycerides…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE